$heff's $tation of $tocks & $olid DD

[InvestorSuisse]

CRMD - CorMedix Inc. Abstracts Accepted for Presentation at American Society of Nephrology Kidney Week 2015

CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal and infectious diseases, today announced that the American Society of Nephrology has accepted two abstracts for poster presentation at Kidney Week 2015. The data to be presented highlight the economic burden of central venous catheter complications to the healthcare system.

“Infection and thrombosis are two complications from long-term catheter use that can lead to significant healthcare costs,” said Antony Pfaffle, M.D., Chief Scientific Officer and Co-Founder, CorMedix. “This is an important issue and we are pleased that this data was recognized by the American Society of Nephrology for presentation to its members and healthcare professionals at this key meeting.”

The abstracts submitted and selected for poster presentation include:

Source: http://investordd.com/cormedix-inc-abstracts-accepted-for-presentation-at-american-society-of-nephrology-kidney-week-2015/